Study author | Year | n/N | Pre-existing heart failure | Age, years | Male, % | BMI, kg/m2 | HTN, % | CAD, % | Diabetes, % | Mean follow-up, years | Outcomes measured* |
Benotti et al 30 | 2017 | 1724/1724 | No | 45/45.1 | 13/13 | 46.5/46.5 | NR | NR | 28/28 | 5.8/6.7‡ | 1 |
Garza et al 28 | 2010 | 18/22 | Yes | 52 | 50 | NR | NR | NR | NR | 3.6 | 5,6 |
Ikramuddin et al 31 | 2015 | 60/59 | No | 49/49 | 37/43 | 34.3/34.9 | NR | NR | NR | 2/2 | 1 |
Johnson et al 32 | 2013 | 2580/13 371 | No | 47.5/52.1 | 23/32.6 | NR | 82.6/82.1 | 8.6/16.4 | 100/100 | 2.3/2.6 | 1 |
Karason et al 33 | 2013 | 2010/2037 | No | 46.1/47.4 | 29.4/29 | NR | NR | NR | NR | 14.7/14.7‡ | 1 |
Miranda et al 26 | 2013 | 13/6 | Yes | 62/69 | 24.1/33.2 | 55/42 | 92/100 | 31/50 | 77/33 | 4.3/2.7‡ | 3,4,6 |
Persson et al 34 | 2017 | 22 295/25 564 | No | 40.7/44.3 | 38/83 | NR | 21.7/17.8 | 2.7/4.7 | 14.9/11.8 | 3.9/5.4 | 1 |
Ramani et al 18 | 2008 | 12/10 | Yes | 41/45 | 25/40 | 53/47 | 75/60 | NR | 50/60 | 1/1 | 2, 3, 5, 6 |
Sanchis et al 35 | 2015 | 108/90 | No | 44/44 | 28/38 | 46.9/45.4 | 50/41 | NR | 30/14 | 1/1 | 1 |
Shimada et al 27† | 2016 | 524 | Yes | 49 | 30.2 | NR | NR | NR | NR | 2 | 2 |
Sundström et al 36 | 2017 | 25 804/13 701 | No | 41.3/41.5 | 23.7/22.8 | 41.5/41.4 | NR | 1.1/0.8 | NR | 4.1/4.1‡ | 1 |
Vest et al 29 | 2016 | 38/38 | Yes | 50.0/50.0 | 47/47 | 47.2/38.2 | 71/63 | 50/34 | 61/47 | 2.6 | 6 |
*Outcomes measured: (1) incidence of heart failure, (2) emergency department evaluation or hospitalisation for HF, (3) HF symptoms, (4) quality of life, (5) change in heart morphology, (6) change in LVEF.
†Study used patient population events 12 months prior to surgery as control for 24 months after surgery.
‡Median follow-up duration.
BMI, body mass index; CAD, coronary artery disease; HTN, hypertension; N, sample size control group; NR, not reported; n, sample size surgical group.